Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.

Cancer biology & therapy - 1 Nov 2008

Chen Shuaili, Auletta Theresa, Dovirak Ostap, Hutter Christina, Kuntz Karen, El-ftesi Samira, Kendall Jude, Han Haiyong, Von Hoff Daniel D, Ashfaq Raheela, Maitra Anirban, Iacobuzio-Donahue Christine A, Hruban Ralph H, Lucito Robert

Abstract excerpt

Pancreatic cancer is one of the most lethal of all cancers. The median survival is six months and less than 5% of those diagnosed survive five years. Recurrent genetic deletions and amplifications in 72 pancreatic adenocarcinomas, the largest sample set analyzed to date for pancreatic cancer, wer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 19
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Dosage

Share to Neoplasm Transplantation

Share to p21-Activated Kinases

Share to Pancreatic Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 18836286
DOI: 10.4161/cbt.7.11.6840
PMCID: PMC7323936

Genes

PAK4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18836286-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.PMID 18836286Read ↗

High-Resolution Genomic and Expression Profiling Reveals 105 Putative Amplification Target Genes in Pancreatic CancerSemantic proximity Read ↗

Characterization of the 7q21‐q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancerSemantic proximity Read ↗

High-resolution characterization of the pancreatic adenocarcinoma genomeSemantic proximity Read ↗

Comprehensive Genomic Profiling of Pancreatic Acinar Cell Carcinomas Identifies Recurrent <i>RAF</i> Fusions and Frequent Inactivation of DNA Repair GenesSemantic proximity Read ↗

Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer.Semantic proximity Read ↗

Genome profiling of pancreatic adenocarcinoma.Semantic proximity Read ↗

Genome-Wide Array-Based Comparative Genomic Hybridization Reveals Multiple Amplification Targets and Novel Homozygous Deletions in Pancreatic Carcinoma Cell LinesSemantic proximity Read ↗

Genomic landscape of pancreatic neuroendocrine tumors.Semantic proximity Read ↗

Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotide polymorphism array.Semantic proximity Read ↗

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancerSemantic proximity Read ↗

Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer.Semantic proximity Read ↗

Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.